CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases 2020

Biocon  /  News – Posts  /  Press Releases  /  Press Releases 2020

Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US

Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US
  • Posted by: BIOCON

Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents

Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents
  • Posted by: BIOCON

Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs

  • Posted by: BIOCON

Biocon Ranked Among Top 5 Biotech Employers Globally

  • Posted by: BIOCON

Biocon Q2FY21 Revenue at Rs 1,760 Cr, Up 10%; EBITDA at Rs 407 Cr; Net Profit (before exceptional item & discontinuing operations) at Rs 174 Cr; Generics Up 8% at Rs 599 Cr; Biosimilars Up 11% at Rs 676 Cr; Research Services Up 12% at Rs 520 Cr.

  • Posted by: BIOCON

Biocon Foundation Signs MoU with Bangalore Metro to Contribute Towards Building Metro Station in Hebbagodi

  • Posted by: BIOCON

Biocon Biologics to Roll Out ‘Mission 10 cents’ in Philippines; Signs MoU with 2 Municipal Governments & reach52 to enable Affordable Access to Quality Insulins

  • Posted by: BIOCON

Biocon appoints Anupam Jindal as its Chief Financial Officer

  • Posted by: BIOCON

Biocon Biologics and Mylan Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes

  • Posted by: BIOCON

Tata Capital Growth Fund to Invest ~USD 30 million (Rs 225 Crore) in Biocon Biologics for an Equity Stake of 0.85% Deal Values Biocon Biologics at USD 3.5 Billion.

  • Posted by: BIOCON
Share
Previous Next
Close
Test Caption
Test Description goes like this